Factors associated with anxiety and depression in men undergoing fertility investigations: a cross-sectional study

被引:2
|
作者
Kooli, Rim [1 ]
Sallem, Amira [1 ,2 ]
Chebil, Dhekra [3 ]
Boussabbeh, Manel [1 ,4 ]
Mohamed, Bochra Ben [5 ]
Ajina, Tesnim [1 ]
Boughzela, Ines [1 ]
Mougou, Soumaya [6 ]
Mehdi, Meriem [1 ,2 ]
机构
[1] Fattouma Bourguiba Univ, Teaching Hosp, Matern & Neonatol Ctr, Lab Cytogenet & Reprod Biol, Monastir, Tunisia
[2] Univ Monastir, Fac Med Monastir, Lab Histol Embryol & Cytogenet LR 18 40, Monastir, Tunisia
[3] Univ Sousse, Fac Med Sousse, Sousse, Tunisia
[4] Univ Monastir, Fac Dent Monastir, Lab Res Biolog Compatible Subst, Monastir, Tunisia
[5] Fattouma Bourguiba Univ, Teaching Hosp, Psychiat Serv, Monastir, Tunisia
[6] Farhat Hached Univ, Teaching Hosp, Lab Human Cytogenet & Reprod Biol, Sousse, Sousse, Tunisia
关键词
Anxiety; Depression; Male infertility; Semen analysis; Tunisia; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL-ASPECTS; SEMEN QUALITY; INFERTILITY; FERTILIZATION; ADAPTATION; COUPLES; PLASMA;
D O I
10.1186/s40359-023-01330-z
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
BackgroundInfertility is a real public health issue because of its medical, socio-cultural, and financial impact. It does also have heavy psychological consequences on both partners. This study aimed to assess levels of anxiety and depression among men undergoing infertility investigation and to identify their associated factors.MethodsWe conducted a cross-sectional study in the Laboratory of Cytogenetics and Reproductive Biology of Fattouma Bourguiba University Teaching Hospital (Monastir, Tunisia) between August 30th, 2020, and March 16th, 2021. Anxiety and depression levels were assessed using the valid Arab version of the Hospital Anxiety and Depression scale (HAD). Semen parameters were analyzed and interpreted according to 2021 World Health Organization (WHO) guidelines.ResultsA total of 282 men were included in the current study. The mean HAD-D (depression) and HAD-A (anxiety) scores were of 6.56 +/- 3.07 (IQR [4-8]) and 7.94 +/- 3.73 (IQR[5-10]) respectively. Univariate analysis showed that patients having two or more comorbidities were nearly five times more likely to be anxious than those without or with only one comorbidity (ORc = 4.71; p = 0.007). Furthermore, single patients were about four times more anxious than those in couple having primary or secondary infertility (ORc = 3.85; p = 0.027). With regards to semen parameters, patients having hypospermia were more than two times anxious compared with those with normal semen volume (ORc = 2.33; p = 0.034). As for depression, we observed that patients with an infertility history lasting for a year or more have a nine times greater risk of depression (ORc = 9.848; p = 0.007). With regards to semen parameters, patients exhibiting two or more semen abnormalities, teratozoospermia and increased MAI were more depressed (ORc = 2.478; p = 0.036; ORc = 2.549: p = 0.023; ORc = 2.762; p = 0.036). Furthermore, we found a negative correlation between HAD-A scores and patient's age.ConclusionsWe pointed out through the current study the associated factors with anxiety and depression in patients under fertility management to precociously identify those who need psychological counseling and hence to better manage infertility issues.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Predictors and incidence of depression and anxiety in women undergoing infertility treatment: A cross-sectional study
    Wang, Lingyan
    Tang, Youyin
    Wang, Yuyang
    [J]. PLOS ONE, 2023, 18 (04):
  • [22] Prevalence of depression and anxiety and associated factors among geriatric orthopedic trauma inpatients: A cross-sectional study
    Chen, Jia-Lei
    Luo, Rong
    Liu, Ming
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (03) : 919 - 928
  • [23] Prevalence of and factors associated with depression and anxiety in patients with rheumatoid arthritis: A multicenter prospective cross-sectional study
    Katchamart, Wanruchada
    Narongroeknawin, Pongthorn
    Chanapai, Wanwisa
    Thaweeratthakul, Phakhamon
    Srisomnuek, Ananya
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (03) : 302 - 308
  • [24] Prevalence and associated risk factors for anxiety and depression in infertile couples of ART treatment: a cross-sectional study
    Zhang, Li
    Shao, Hongfang
    Huo, Mian
    Chen, Jie
    Tao, Minfang
    Liu, Zhangshun
    [J]. BMC PSYCHIATRY, 2022, 22 (01)
  • [25] The prevalence and associated factors of prenatal depression and anxiety in twin pregnancy: a cross-sectional study in Chongqing, China
    Ying Zhou
    Jingui Huang
    Philip N. Baker
    Bizhen Liao
    Xinyang Yu
    [J]. BMC Pregnancy and Childbirth, 22
  • [26] Frequency and Associated Factors for Anxiety and Depression in Pregnant Women: A Hospital-Based Cross-Sectional Study
    Ali, Niloufer S.
    Azam, Iqbal S.
    Ali, Badar S.
    Tabbusum, Ghurnata
    Moin, Sana S.
    [J]. SCIENTIFIC WORLD JOURNAL, 2012,
  • [27] Prevalence and associated risk factors for anxiety and depression in infertile couples of ART treatment: a cross-sectional study
    Li Zhang
    Hongfang Shao
    Mian Huo
    Jie Chen
    Minfang Tao
    Zhangshun Liu
    [J]. BMC Psychiatry, 22
  • [28] Prevalence of depression and anxiety and associated factors among geriatric orthopedic trauma inpatients: A cross-sectional study
    Jia-Lei Chen
    Rong Luo
    Ming Liu
    [J]. World Journal of Clinical Cases, 2022, (03) : 919 - 928
  • [29] Risk factors of anxiety and depression in children and adolescents with headache: A cross-sectional study
    Rousseau-Salvador, C.
    Amouroux, R.
    Gooze, R.
    Salvador, A.
    Tourniaire, B.
    Rusinek, S.
    Annequin, D.
    [J]. EUROPEAN REVIEW OF APPLIED PSYCHOLOGY-REVUE EUROPEENNE DE PSYCHOLOGIE APPLIQUEE, 2013, 63 (05): : 295 - 302
  • [30] Depression and anxiety in patients with cancer: Prevalence and risk factors: A cross-sectional study
    Naser, Abdallah Y.
    Hameed, Anas Nawfal
    Mustafa, Nour
    Alwafi, Hassan
    Dahmash, Eman Zmaily
    Alyami, Hamad S.
    Khalil, Haya
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 189 - 189